1-5 of 5
Lynn Bratby
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is Daily Lenograstim From Day +7 Of Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) Is As Effective As Pegfilgrastim In Patients With Myeloma?

Ben Bailiff, Neil Phillips, Vidhya Murthy, Lynn Bratby, Kathy Holder, Bhuvan Kishore, E Nikolousis, R Lovell, Guy Pratt, Joanne Ewing, Shankaranarayana Paneesha
Journal: Blood
Blood (2013) 122 (21): 5538.
https://doi.org/10.1182/blood.V122.21.5538.5538
Published: 2013
Journal Articles

Autologous Stem Cell Transplant Has a Role In Consolidating Chemotherapy Given At First Disease Progression In Multiple Myeloma Treated Exclusively With Novel Agents

Bhuvan Kishore, Shankaranarayana Paneesha, Syed W Bokhari, Shrinivas Pillai, Jason Sangha, Sandeep Nagra, MD, Emmanouil Nikolousis, Dewi Tomos Eden, MRCP, MB, Mark Crowther, MBChB, Prem Mahendra, Joanne Ewing, Guy Pratt, Neil Smith, Vidhya Murthy, Clare Gardner, Richard Lovell, Kamaraj Karunanithi, Richard Christopher Chasty, MBBS, FRCP, FRCPath, Karen Yarwood, Lynn Bratby, Kathy Holder, Baker Lynda, Julie Suhr, Pip Nicolson, MD, Mark Cook
Journal: Blood
Blood (2013) 122 (21): 5514.
https://doi.org/10.1182/blood.V122.21.5514.5514
Published: 2013
Journal Articles

Full Donor T Cell Chimerism Predicts Transplant Outcomes In High Risk AML But Not In Intermediate Risk AML After a T-Deplete Alemtuzumab Conditioned Transplant

Amy Gudger, Vidhya Murthy, Duncan J Murray, MA MRCP, Ben Bailiff, Maria Mushkbar, Jonathan ray Lancashire, MBBS, MRCP, Phillip Nicolson, Kathy Holder, Lynda Baker, Lynn Bratby, Bhuvan Kishore, Richard Lovell, Shankaranarayana Paneesha, Nikolousis Emmanouil, MRCP, FRCPath, Ph.D
Journal: Blood
Blood (2013) 122 (21): 5545.
https://doi.org/10.1182/blood.V122.21.5545.5545
Published: 2013
Journal Articles

Pre-Transplantation Assessment Of Mortality (PAM) Score Is a Poor Predictor For Survival In The Highest Risk Group When Used In T Cell Depleted Myeloablative Allogeneic Transplants

Bhuvan Kishore, Daniel Wiseman, MBChB, MRCP, Emmanouil Nikolousis, Richard Lovell, Donald Milligan, MD, Kathy Holder, Lynn Bratby, Vidhya Murthy, Shankaranarayana Paneesha
Journal: Blood
Blood (2013) 122 (21): 5553.
https://doi.org/10.1182/blood.V122.21.5553.5553
Published: 2013
Journal Articles

Transplant Outcome Is Not Affected by Body Mass Index (BMI) in Patients with Haematological Malignancies.

Emmanouil Nikolousis, Shankaranarayana Paneesha, MD MRCP MRCPath, Kathy Holder, Lynn Bratby, Srinivas Pillai, Richard Lovell, Don Milligan, MD FRCP FRCPath
Journal: Blood
Blood (2007) 110 (11): 1991.
https://doi.org/10.1182/blood.V110.11.1991.1991
Published: 2007